Find Research Outputs

Search results

• Article

  A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity scoreanalysis.

  Carroccio, A., Cottone, M., Siringo, S., Mocciaro, F., Renna, S., Orlando, R., Carroccio, A., Macaluso, F. S., Carroccio, A., Mendolaro, M., Pluchino, D., Ventimiglia, M., Garufi, S., Ferracane, C., Pisana, V., Carroccio, A., Siringo, S., Magnano, A., Inserra, G., Di Mitri, R. & 6 others, Privitera, A. C., Magnano, A., Orlando, A., Fries, W., Cappello, M. & Scarpulla, G., 2018, In: Digestive and Liver Disease. 50, p. 1292-1298 7 p.

  Research output: Contribution to journal › Article › peer-review

  • golimumab
  • Adalimumab
  • Ulcerative Colitis
  • Propensity Score
  • Treatment Failure
  6 Citations (Scopus)

• Clinical benefit of vedolizumab on articular manifestations in patients with active spondyloarthritis associated with inflammatory bowel disease

  Ciccia, F., Cottone, M., Cottone, M., Renna, S., Orlando, R., Rizzo, A., Macaluso, F. S., Orlando, A., Orlando, A., Macaluso, F. S., Orlando, R. & Renna, S., 2017, In: Annals of the Rheumatic Diseases. 76, p. e31-e31 2 p.

  Research output: Contribution to journal › Article › peer-review

  27 Citations (Scopus)

• CLINICAL COURSE OF SEVERE COLITIS: A COMPARISON BETWEEN CROHN'S DISEASE AND ULCERATIVE COLITIS.

  Cappello, F., Tomasello, G., Leone, A., Sinagra, E., Cottone, M., Cottone, M., Mocciaro, F., Rizzo, A., Sinagra, E., Scalisi, A., Seta, Tomasello, Maisano, S., Solina, Giunta, M., Orlando, A., Oliva, Criscuoli, V. & Mocciaro, F., 2018, In: JOURNAL OF BIOLOGICAL REGULATORS & HOMEOSTATIC AGENTS. 32, p. 415-423 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Colectomy
  • Colitis
  • Ulcerative Colitis
  • Crohn Disease
  • Megacolon
  1 Citation (Scopus)

• Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).

  Cottone, M., Carroccio, A., Cottone, M., Siringo, S., Alibrandi, A., Mocciaro, F., Renna, S., Carroccio, A., Macaluso, F. S., Viola, A., Ventimiglia, M., Garufi, S., Ferracane, C., Magrì, G., Vitello, A., Bertolami, C., Porcari, S., Carroccio, A., Belluardo, N., Siringo, S. & 9 others, Magnano, A., Fidanza, O., Porcari, S., Inserra, G., Di Mitri, R., Privitera, A. C., Orlando, A., Fries, W. & Cappello, M., 2020, In: DRUGS & AGING. 10 p.

  Research output: Contribution to journal › Article › peer-review

  • Inflammatory Bowel Diseases
  • Tumor Necrosis Factor-alpha
  • Therapeutics
  • Ulcerative Colitis
  • Coinfection
  3 Citations (Scopus)
• Other

  A real life comparison of the efficacy of adalimumab versus golimumab in moderate-to-severe ulcerative colitis. A multicenter experience from the sicilian network for inflammatory bowel disease (SN-IBD)

  Carroccio, A. & Cottone, M., 2017, p. 750-750. 1 p.

  Research output: Contribution to conference › Other › peer-review

  • golimumab
  • Adalimumab
  • Ulcerative Colitis
  • Inflammatory Bowel Diseases

• The sicilian network for inflammatory bowel disease (SN-IBD): preliminary data on efficacy of biological therapy.

  Carroccio, A., Accomando, S. & Cottone, M., 2017, p. 740-740. 1 p.

  Research output: Contribution to conference › Other › peer-review

  • Biological Therapy
  • Infliximab
  • Preliminary Data
  • Inflammatory Bowel Diseases
  • Adalimumab

• The sicilian network of biological therapy in inflammatory bowel disease: preliminary data from a prospective study on efficacy and safety

  Carroccio, A., Accomando, S. & Cottone, M., 2017, p. 91-91. 1 p.

  Research output: Contribution to conference › Other › peer-review

  • Biological Therapy
  • Preliminary Data
  • Inflammatory Bowel Diseases
  • Biosimilar Pharmaceuticals
  • Prospective Studies
• Paper

  Sicilian Network for Inflammatory Bowel Disease (SN-IBD). A propensity score-matched comparison of infliximab and adalimumab in naïve and non-naïve patients with Crohn’s disease.

  Orlando, A.; Macaluso, F.; Fries, W.; Privitera, A.; Cappello, M.; Siringo, S.; Inserra, G.; Magnano, A.; Di Mitri, R.; Belluardo, N.; Scarpulla, G.; Magrì, G.; Trovatello, N.; Genova, S.; Bertolami, C.; Vassallo, R.; Ventimiglia, M.; Renna, S.; Orlando, R.; Rizzuto, G., 2018.

  Research output: Contribution to conference › Paper › peer-review

• The Sicilian network of biological therapy in inflammatory bowel disease: preliminary data on efficacy .

  Orlando, A.; Macaluso, F.; Fries, W.; Privitera, A.; Cappello, M.; Siringo, S.; Inserra, G.; Magnano, A.; Di Mitri, R.; Belluardo, N.; Scarpulla, G.; Magrì, G.; Trovatello, N.; Genova, S.; Calandruccio, G.; Vassallo, R.; Romano, C.; Pellegrino, S.; Citrano, M.; Ventimiglia, M.; Renna, S.; Orlando, R.; Rizzuto, G.; Vinci, E., 2017.

  Research output: Contribution to conference › Paper › peer-review
• Review article

  Six year adalimumab efficacy in steroid-dependent Crohn's disease patients: A prospective single-center real life study

  Cottone, M., Craxi, A., Mocciaro, F., Di Mitri, R., Giunta, M., Orlando, A., Orlando, E., Rizzuto, G., Affronti, M., Mendolaro, M., Giunta, M. A. & Renna, S., 2016, In: Digestive and Liver Disease. 48, p. 1314-1317 4 p.

  Research output: Contribution to journal › Review article › peer-review

  • Adalimumab
  • Crohn Disease
  • Steroids
  • Safety
  • Lost to Follow-Up
  2 Citations (Scopus)